Clinical Trials
21 trialsA Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension
Shanghai Chest Hospital
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Minghui Pharmaceutical (Hangzhou) Ltd
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma
Chongqing Precision Biotech Co., Ltd
Study of JS004 Combined With Toripalimab for Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
Hunan Province Tumor Hospital
WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
Innovent Biologics (Suzhou) Co. Ltd.
A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Descriptors and Predictors of Burden and Information Needs
Chulabhorn Cancer Center
CAR-T Cell Immunotherapy for Advanced Lung Cancer
Sun Yat-sen University
Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator
Chung Shan Medical University
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
EQUIP
National Cancer Centre, Singapore